Real-time enrollment status for this multiple sclerosis clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 7:18 AM UTC
| NCT Number | NCT06220669 |
| Recruiting Status | Recruiting |
| Condition | Multiple Sclerosis |
| Phase | Clinical Trial |
| Target Enrollment | 200 participants |
| Active Locations | 16 sites in the US |
| Sponsor | Eli Lilly and Company |
| Last Updated on CT.gov | December 9, 2025 (Dec 9, 2025) |
As of March 2, 2026: Clinical trial NCT06220669 is currently recruiting participants. This clinical trial study for multiple sclerosis is actively seeking new participants at 16 locations across the United States. The study is sponsored by Eli Lilly and Company. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06220669 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 16 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06220669 was last updated Dec 9, 2025 (December 9, 2025). HelloStudys verifies this status automatically.